Conatus Pharmaceuticals Garners $1,001,551 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0b66bac6-1368-4408-acd9-401c64fe6d55&Preview=1 - Date
6/14/2013 - Company Name
Conatus Pharmaceuticals - Mailing Address
4365 Executive Drive San Diego, CA 92121 - Company Description
The Conatus team pioneered the science of apoptosis and the clinical development of pan caspase inhibitors, validating this first-in-class technology. Conatus has well established relationships with key opinion leaders in the fields of hepatology, infectious disease and inflammation. - Website
http://www.conatuspharma.com - Transaction Type
Debt - Transaction Amount
$1,001,551 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
